D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the coronavirus disease-19 (COVID-19) is still challenging healthcare systems and societies worldwide. While vaccines are available, therapeutic strategies are developing and need to be adapted to each patient. Many clinical ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Jungwirth, Johannes, Häring, Clio, König, Sarah, Giebeler, Liane, Doshi, Heena, Brandt, Christian, Deinhardt-Emmer, Stefanie, Löffler, Bettina, Ehrhardt, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266999/
https://www.ncbi.nlm.nih.gov/pubmed/35805887
http://dx.doi.org/10.3390/ijms23136880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266999/
https://www.ncbi.nlm.nih.gov/pubmed/35805887
http://dx.doi.org/10.3390/ijms23136880

Ejemplares similares